Latest / Stock Movers / Closing Bell: HIMS Surges, Uber & DoorDash Sinks, Paramount Drops
Transcript
- 0:02Speaker 1: Bloomberg Audio Studios, Podcasts, radio News.
- 0:10Speaker 2: This is the closing bell on the stock Movers report
- 0:13Speaker 2: the company's making moves at the close of US trading
- 0:16Speaker 2: with Carol Masser, Tim stenovek Romain Bostik, and Katie Greyfell. Hey,
- 0:22Speaker 2: let me go.
- 0:23Speaker 3: To some of the individual gainers. I'm sure you guys
- 0:25Speaker 3: talked about it. YMS and HER's Health and Novo Nordisks
- 0:29Speaker 3: HIMS and hers Health biggest move that we've seen most
- 0:33Speaker 3: ever in fact inter day and I'm assuming here at
- 0:36Speaker 3: the close up about forty almost forty one percent. This
- 0:39Speaker 3: happening after Nova Nordisks was said to have ended its
- 0:42Speaker 3: public feud, with the company ending litigation with an agreement
- 0:45Speaker 3: to actually sell its weight loss drugs on the hymns platform.
- 0:49Speaker 3: So we did see Hyms a big move to the upside.
- 0:51Speaker 3: Nova Nordisk, which has been struggling as it tries to
- 0:54Speaker 3: find its way in what has become an increasingly competitive
- 0:57Speaker 3: JLP one landscape, it too, up about three point one percent,
- 1:01Speaker 3: so we've got that playing out. Also, kind of staying
- 1:05Speaker 3: in the drugs and biotech space, a lot of movement
- 1:08Speaker 3: in the area for some companies, and some of it
- 1:10Speaker 3: has to do with the head of the FDA's Division
- 1:13Speaker 3: of Vaccines and Gene Therapies set to leave the agency
- 1:17Speaker 3: next month. We talked with Bloomberg's Medicin Mueller. This is
- 1:19Speaker 3: a pretty big deal for some companies in the biotech
- 1:22Speaker 3: space or the space overall, so capricor therapeutics. It's a
- 1:26Speaker 3: one point six billion dollar market cap, clinical stage biotech.
- 1:29Speaker 3: It's working on biological therapies. That one was up almost
- 1:32Speaker 3: ten percent in today's session, has been higher all day.
- 1:35Speaker 3: And then another one regen x Bio, also a clinical
- 1:38Speaker 3: stage biotech companies small market cap about five hundred and
- 1:42Speaker 3: forty two million market cap there developing gene therapy products.
- 1:46Speaker 3: But that one too, the expectation maybe a better and
- 1:49Speaker 3: some more supportive landscape from the FDA for these kinds
- 1:53Speaker 3: of companies and the work that they're doing. That one
- 1:55Speaker 3: was up about twenty percent. And then just quickly, let's
- 1:57Speaker 3: go on over to Live Nation News for that one.
- 2:01Speaker 3: The company and its ticket master subsidiary have reached a
- 2:04Speaker 3: settlement with federal anti trust authorities. According to the Justice Department.
- 2:07Speaker 3: The agreement announced, but it would reportedly open up parts
- 2:11Speaker 3: of Live Nation's ticketing armed to third party sellers make
- 2:14Speaker 3: it easier for other promoters to put on shows that amphitheaters,
- 2:18Speaker 3: that live nation controls, and you can see that one.
- 2:21Speaker 3: Whenever you get rid of some litigation overhead overhang, you
- 2:24Speaker 3: can see it pop to the pside up about six
- 2:27Speaker 3: point two percent. That's what it's going to add.
- 2:28Speaker 1: A couple honorable mentions here, just that big movement we saw,
- 2:31Speaker 1: of course in Lamentum earlier today, along with a vertive
- 2:33Speaker 1: incoherent of course, going to be added to the S
- 2:36Speaker 1: and B five hundred at the end of March twenty third.
- 2:40Speaker 4: Well, let's look up some of the names in the red.
- 2:42Speaker 4: I mean, this was a day that we ended up
- 2:44Speaker 4: seeing a bit of reversal in the market, but digging
- 2:46Speaker 4: into some of the decline.
- 2:47Speaker 3: You had to scramble to make some changes.
- 2:49Speaker 4: We did see a lot of changes. I'm squeaking my
- 2:51Speaker 4: names up until the closing bell, but taking a look
- 2:54Speaker 4: at Boeing, this is a stock that ended lower by
- 2:57Speaker 4: about two point six percent on the day. We got
- 2:59Speaker 4: some headlines crossing the Bloomberg terminal earlier today saying that
- 3:02Speaker 4: the Iran war has airlines reviewing growth plans as fuel
- 3:05Speaker 4: costs rise. We heard that some airlines were considering halting
- 3:09Speaker 4: jet deliveries, which we know when we think about contracts
- 3:11Speaker 4: with Boeing, a lot of these things are done far out,
- 3:14Speaker 4: so really just casting some uncertainty here in the market.
- 3:17Speaker 4: Some airlines were said to also pause leasing and order discussions,
- 3:21Speaker 4: so you certainly saw that weighing on sentiment here for
- 3:24Speaker 4: investors of Boeing. But keeping an eye on all the
- 3:27Speaker 4: implications that we've been seeing in terms of the ongoing
- 3:30Speaker 4: conflict in the Middle East. Of course, we've got the
- 3:32Speaker 4: headlines coming out earlier about what the outlook could be
- 3:35Speaker 4: and how long this actual conflict could last. But there
- 3:38Speaker 4: were some stocks that of course have exposure to the
- 3:41Speaker 4: oil space, and taking a look at shares of Uber,
- 3:45Speaker 4: they ended lower by about one point seven percent, door
- 3:47Speaker 4: Dash and Focus that went down about one zero point
- 3:50Speaker 4: four percent at the closing bell. Now, this of course
- 3:53Speaker 4: is due to the idea that these companies actually have
- 3:55Speaker 4: exposure to the costs for fuel oil and the idea
- 4:00Speaker 4: that these all this pressure could really trickle out into
- 4:03Speaker 4: the consumer and make things more expensive. We know ubers,
- 4:05Speaker 4: at least here in New York City are already expensive,
- 4:08Speaker 4: with a lot of these surcharges, but thinking about that
- 4:10Speaker 4: just actually coming into door Dash and Uber and whether
- 4:14Speaker 4: or not that could actually weigh on consumers and the
- 4:17Speaker 4: companies more broadly, and lastly, wrapping things up, I've got
- 4:20Speaker 4: my eyes on Paramounts Guidance. We know that this is
- 4:22Speaker 4: a story that's really been evolving day after day. If
- 4:25Speaker 4: we think about Paramounts Guidance and Warner Brothers Discovery, that
- 4:28Speaker 4: battle that we saw between Paramounts Guidance and Netflix that
- 4:31Speaker 4: we know paramount did win here. So we do see
- 4:33Speaker 4: shares down about six point seven percent on the day.
- 4:35Speaker 4: This is after ten cents at an intense a best
- 4:38Speaker 4: several hundred million dollars.
- 4:40Speaker 2: The Stock Movers Report from Bloomberg Radio. Check back with
- 4:44Speaker 2: us throughout the day for the latest roundup of companies
- 4:47Speaker 2: making news on Wall Street and for the latest market
- 4:50Speaker 2: moving headlines. Listen to Bloomberg Radio Live, catch us on YouTube,
- 4:55Speaker 2: Bloomberg dot com, and on Applecarplay and Android Auto with
- 4:58Speaker 2: the Bloomberg Business Up
- 5:04Speaker 1: H